Healthcare VC Founder Meeting Prep

Reviewed by Fallon Han· Updated 2026-05-22 18:50:08.416

This conversation was generated using Cook'd AI's career assistant and reviewed by Fallon Han from our editorial team for accuracy.

I have a founder meeting for an early-stage fund in New York. I am an MBA grad from healthcare administration, and I want to practice a startup founder interview. Can you run a realistic conversation that tests whether I have venture fit, especially on empathy, market sizing, and diligence on product-market fit?

Absolutely. I will play the founder of a digital health startup raising a seed round in New York. Your job is to interview me like a venture investor and decide if the company is worth deeper diligence. Focus on three things: 1. Empathy for the founder and customer pain 2. Market sizing with clear, defensible assumptions 3. Product-market fit diligence, including evidence of demand and retention I will answer as the founder. After the conversation, I can also score your performance and give a concise evaluation report. Founder enters the room and says: Thanks for making time. We are building a workflow platform for outpatient specialty clinics to reduce referral leakage and automate patient intake. We have three pilot clinics live and want to raise a seed round.

Thanks for the intro. Before we talk numbers, I want to understand the pain in a practical way. What problem did you see in those clinics that convinced you this is urgent enough for them to change behavior and pay for a new system?

Great question. In the clinics we worked with, referrals were being lost because staff relied on manual spreadsheets, faxed records, and inconsistent follow-up. Patients waited too long, referral sources got frustrated, and the clinics could not easily see where the bottlenecks were. The urgency showed up in two places: revenue leakage and staff overload. One clinic estimated that 12 to 15 percent of referred patients never completed scheduling. Another told us their front desk team spent several hours a day chasing forms and insurance details. They did not want another tool unless it clearly reduced that burden.

That helps. How do you know this is a real market and not just a nice workflow improvement? Walk me through your market sizing from the bottom up, and tell me who the first ideal buyer is.

Our initial buyer is an independent specialty clinic with 5 to 30 providers, especially orthopedics, cardiology, and gastroenterology. They feel the referral and intake pain acutely but do not have the IT stack of a large health system. For sizing, we start with the number of outpatient specialty practices in the U.S., then narrow to clinics with enough referral volume and operational complexity to pay for software. From there, we estimate annual software spend per clinic in the low five figures. Our bottom-up view suggests a serviceable market in the hundreds of millions, with expansion potential into adjacent ambulatory settings. We are not claiming the whole U.S. healthcare market, just the segment that has clear urgency and budget.

I appreciate the focus. On product-market fit, what evidence do you have beyond pilots? I want to know whether users keep coming back, whether someone is willing to pay, and whether the pain is strong enough that this becomes a must-have rather than a nice-to-have.

So far, the strongest signal is engagement inside the pilots. Clinic staff are using the platform daily because it replaces a manual process they already hate. We also have one pilot that converted into a paid contract after the trial period, which was important validation. That said, we are still early. We do not yet have broad retention data, and we are watching whether the value remains strong after the initial implementation excitement fades. Our hypothesis is that if the product consistently saves staff time and lifts referral conversion, it becomes embedded in workflow and harder to remove. We are actively testing whether the buyer cares more about operational efficiency or revenue lift, because that will shape our sales message.

Last question. If I were your investor, what would concern me most about this company, and how would you answer that concern honestly?

The biggest concern is whether hospitals and clinics are willing to adopt another workflow tool in a fragmented and slow-moving market. Even if the pain is real, healthcare buying can be delayed by integrations, compliance review, and staff resistance. My honest answer is that we are not pretending implementation risk does not exist. We are mitigating it by starting with independent clinics, keeping onboarding light, and proving value fast with a narrow use case. I would also say that our first job is not to boil the ocean. It is to prove repeatable wins in a single buyer segment, then expand from there. If you like, I can now grade your interview on empathy, market sizing, and diligence quality with specific feedback.